Skip to main content
. 2022 Nov 8;41(9):1670–1683. doi: 10.1200/JCO.22.01214

TABLE 1.

Clinical and Biologic Features of the 194 Patients With Refractory Leukemia or Hematologic Relapse and the Comparison of EFS Between the 78 Patients Who Received Consolidation Hematopoietic Cell Transplantation and the 116 Who Did Not According to Various Features

graphic file with name jco-41-1670-g003.jpg